Evidence map›Paper›PMID 31231671›Full record

ArticleCogent medicine2017

Developmental exposures to bisphenol S, a BPA replacement, alter estrogen-responsiveness of the female reproductive tract: a pilot study.

Corinne E Hill, Sarah A Sapouckey, Alexander Suvorov, Laura N Vandenberg

Abstract read
In one paragraph

Article in Cogent medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Obesity and endocrine-disrupting chemicals.Endocrine connections · 2021
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. The impact of bisphenol S on bovine granulosa and theca cells.Reproduction in domestic animals = Zuchthygiene · 2018
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Corinne E HillDepartment of Environmental Health Sciences, School of Public Health and Health Sciences, University of Massachusetts - Amherst.
Sarah A SapouckeyDepartment of Environmental Health Sciences, School of Public Health and Health Sciences, University of Massachusetts - Amherst.
Alexander SuvorovDepartment of Environmental Health Sciences, School of Public Health and Health Sciences, University of Massachusetts - Amherst.
Laura N VandenbergDepartment of Environmental Health Sciences, School of Public Health and Health Sciences, University of Massachusetts - Amherst.

Funding

Impact of Environmental Estrogens on Sexually Dimorphic Development of the Mouse Mammary GlandK22ES025811 · NIEHS · UNIVERSITY OF MASSACHUSETTS AMHERST · PI VANDENBERG, LAURA N. · 2015 to 2017
$445k
NIEHS NIH HHS K22 ES025811
6 · The paper itself

Abstract

Developmental exposures to bisphenol A (BPA), an estrogen receptor agonist, can disrupt development of the female reproductive tract in rodents and non-human primates. Due to an increased public knowledge of negative health effects associated with BPA exposure, BPA has begun to be phased out of many consumer products and in some cases it has been replaced with structurally similar compounds including bisphenol S (BPS). This study examined CD-1 mice exposed to a low dose of BPS during early development (200 µg/kg/day from gestational day 8 until postnatal day 19). BPS altered expression of estrogen-responsive genes in both the uterus and ovary, and induced increases in ovarian follicular development in pre-pubertal females evaluated at postnatal day 22. Prior studies have revealed that developmental exposures to environmental chemicals including BPA alter the response of animals to hormonal or carcinogen challenges experienced later in life. To evaluate whether early life exposures to BPS alter responses of females to an estrogen challenge, additional females were exposed to ethinyl estradiol from postnatal day 19 through postnatal day 21. BPS-treated females responded abnormally to this estrogen challenge, displaying heightened responses in the uterus and diminished responses in the ovary. Although additional studies are needed to characterize the mechanisms by which BPS alters the female reproductive tract, this pilot study provides evidence that a common BPA replacement chemical may have endocrine disrupting properties.

Indexed as

apoptosisendocrine disruptorestrogen receptorethinyl estradiolovarian folliclesproliferationpubertyuterine endometrium

Identifiers

PMID31231671
PMCPMC6588183

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.